APPLICATION OF HYPOCHLORITE SODIUM IN INTEGRATED TREATMENT UROGENITAL CHLAMIDIOSIS

Aim. Assess some indicators of cellular and humoral immunity in order to achieve maximum efficacy in the treatment of urogenital chlamydia (UGH) in the combined use of sodium hypochlorite.

Materials and methods. The object of the clinical study was 54 women with verified diagnosis of UGH, 30 of them were included in the treatment regimen, and 24 with furatsilin. Comprehensive examination of patients included: a detailed study of the history, the main complaints and the results of gynecological examination, performing a microscopy of the vaginal smear (on the 1st day of admission, on the 6th day after the vaginal sanitation and at the end of treatment). PCR diagnostics and immunoassay were performed before and after treatment, according to these criteria, the effectiveness of therapy was evaluated.

Results. Chronic course of the disease is recorded in 100% of women, in the anamnesis of 37% of patients – chronic adnexitis, metroendometritis and colpitis of various etiologies. Of the women who turned to us for help (100%), 82% of the patients complained of abundant vaginal discharge, 27% – of dyspareunia, 19% of dysuria and itching of the external genitalia. Only 8% of the women examined did not make any complaints. 76% of the 30 patients who were initially examined had hyperemia of the vaginal mucosa. In the vaginal smear of women suffering from chlamydia, a significant proportion of leukocytes was found (the minimum value is 15,3 in n/sp, the maximum – 19,2 in n/sp). Scheme of treatment for chlamydia is provided for intravaginal sanitation with sodium hypochlorite. In all the examined patients, its tolerance was positive, as a result, the microbiocenosis of the vagina improved due to the elimination of pathogenic and opportunistic microorganisms. The reliability of the clinical effect was confirmed before antibiotics were prescribed.

Conclusion. After the combined use of the sodium hypochlorite in the treatment of chlamydia, the total number of neutrophilic granulocytes and T-lymphocytes, the immunoregulatory index, the relative concentration of cells expressing the activation markers and the normalization of the total content of the main classes of immunoglobulins increase, which indicates the processes of functional recovery in the main parts of the immune system.

1. Адаскевич В.П. Заболевания, передаваемые половым путем. Витебск, 1997: 208-220. [Adaskevich V.P. Diseases transmitted sexually. Vitebsk, 1997: 208-220].

2. Глажова Л.К., Башмакова Н.В., Моторнюк Ю.И., Ремизова И.И. Особенности течения хламидийной инфекции у беременных. Совершенствование диагностики и лечения. Инфекции, передаваемые половым путем. 2002; 2: 15-20 [Glazhova L.K., Bashmakova N.V., Motornyuk Yu.I., Remizova II Features of the course of chlamydia infection in pregnant women. Improving Diagnosis and Treatment. Sexually Transmitted Infections. 2002; 2: 15-20].

3. Хламидийная инфекция. Особенности и диагностические возможности / под ред. М.А. Гомберга, О.Е. Орловой. М.: МЕДАК-Диагностика, 1999: 31 [Chlamydial infection. Features and diagnostic capabilities / Ed. M.A. Gomberg, O.E. Orlova. M.: MEDAK-Diagnostika; 1999: 31].

4. Исаков В.А., Коваленко А.Л., Алексеева Л.Е. и др. Циклоферон: применение в терапии урогенитального хламидиоза и герпетической инфекции: руководство для врачей. СПб., 1997. 40 с. [Isakov V.A., Kovalenko A.L., Alekseeva L.E. et al. Cycloferon: application in therapy of urogenital chlamydia and herpetic infection: a guide for physicians. St. Petersburg, 1997. 40 р.].

5. Кисина В.И. Комбинированная терапия урогенитальных инфекций в амбулаторной практике. Гинекология. 2005; 1: 2629 [Kisina V.I. Combination therapy of urogenital infections in outpatient practice. Gynecology. 2005; 1: 26-29].

6. Козлова В.И., Пухнер А.В. Вирусные, хламидийные и микоплазменные заболевания гениталий: руководство для врачей. 4-е изд. М.: Филинъ; 1997. 536 с. [Kozlova V.I., Pukhner A.V. Viral, chlamydial and mycoplasmal genital diseases: a guide for doctors. 4 th ed. Moscow: Filin; 1997. 536 p.].

7. Кротов С.А., Кротова В.А., Юрьев С.Ю. Хламидиозы: эпидемиология, характеристика возбудителя, методы лабораторной диагностики, лечение генитального хламидиоза: реферативное сообщение. Кольцово; 1997. 63 с. [Krotov S.A. , Krotova V.A., Yuriev S.Yu. Chlamydiosis: epidemiology, characteristics of the pathogen, methods of laboratory diagnosis, treatment of genital chlamydia: referral report. Koltsovo; 1997. 63 р.].

8. Тихомиров А.Л., Сарсания С.И. Воспалительные заболевания органов малого таза. Современные особенности лечения. Врач. 2005; 6: 72-4 [Tikhomirov A.L., Sarsaniya S.I. Inflammatory diseases of the pelvic organs. Modern features of treatment. Vrach. 2005; 6: 72-4].

9. Чеботарев В.В. Урогенитальный хламидиоз: современные проблемы диагностики, патогенеза, лечения. Венерология. 2004; 1: 43-48 [Chebotarev V.V. Urogenital chlamydiosis: modern problems of diagnosis, pathogenesis, treatment. Venerology. 2004; 1: 43-48].

10. Хламидиоз. Клиника, диагностика, лечение: метод. рекомендации. М., 1996. 22 с. [Chlamydia. Clinic, diagnosis, treatment: method. recommendations. M., 1996. 22 р.].

11. Молочков В.А., Гущин А.Е., Балюра Е.В. Вильпрафен в комплексном лечении хронического урогенитального хламидиоза. Сеченовский вестник. 2013; 1(11): 55-58. [Molochkov V.A., Gushchin A.E., Balura E.V. Vilprafen in the complex treatment of chronic urogenital chlamydiosis. Sechenovskii vestnik. 2013; 1 (11): 55-58].

12. Малова И.О., Сидорова И.А., Шеломенцева Н.А. Урогенитальный хламидиоз у женщин репродуктивного возраста: рациональный подход к терапии. Сибирский медицинский журнал. 2013; 2: 046-050. [Malova I.O., Sidorova I.A., Shelomentseva N.A. Urogenital chlamydia in women of reproductive age: rational approach to therapy. Siberian Medical Journal. 2013; 2: 046-050].

13. Дюдюн А.Д., Свирид С.Г., Горбунцов В.В., Нагорный А.Е., Полион Н.Н., Дюдюн С.А. Урогенитальная хламидийная инфекция. Современные аспекты проблемы. Клиническая лекция. Дерматовенерология. Косметология. Сексопатология. 2014; 1-4: 88-113. [Dyudyun A.D., Svirid S.G., Gorbuntsov V.V., Nagorny A.E., Polion N.N., Dyudyun S.A. Urogenital chlamydial infection. Modern aspects of the problem. Clinical lecture. Dermatovenerology. Cosmetology. Sexopathology. 2014; 1-4: 88-113].

14. Batteiger В.E. The major outer membrane protein of a single Chlamydia trachomatis serovar can posses more than one serovar-specific epitope. Infect Immun. 1996; 64: 542-547.

15. Black С.М. Current Methods of laboratory Diagnosis of Chlamydiatrachomatis infections. Clinical Microbiology Reviews Jan. 1997, 160-184.

16. Dieterle S., Rummel C., Bader LW. et al. Presence of the major outer – membrane protein of Chlamydia trachomatis in patients with chronic salpingitis and salpingitis isthmica nodosa with tubal occlusion. Fertil Steril. 1998; 70 (4): 774-6.

17. Everett К.D.E., Bush R.В., Andersen A.A. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkani-aceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five species, and standards for the identification organisms. International Journal of Systematic bacteriology. 1999; 49: 415-440.

18. Gerbase A.C., Rowley J.Т., Mertens T.Е. Global epidemiology of sexually transmitted diseases. Lancet. 1998; 351: 2-4.

19. Lapage S.P., Sneath P.H.A., Lessel E.F. et al. International Code of Nomenclature of Bacteria (1990 Revision). Bacteriological Code. Washington, DC: American Society for Microbiology, 1992.

20. Mittal A., Kapur S., Gupta S. Host immune response in chlamydial cervicitis. Br. J. Biomed Sci. 1996; 53(3): 214-20.

21. Ossewaarde J.М., Meijer A. Molecular evidence for the existence of additional members of the order Chlamydiales. Microbiology. 1999; 145: 411-7.

22. Stephens R.S. et al. Genome Sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science Jet. 1998; 282: 754-759.

23. Theunissen J.J., Minderhoud-Bassie W. et al. Chlamydia trachomatis – specific antibodies in patients with pelvic inflammatory disease: comparison with isolation in tissue culture or detection with polymerase chain reaction. Genitourin Med. 1994; 70(5): 304-7.